Approaches using molecular imaging technology — use of PET in clinical microdose studies
- 19 June 2011
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 63 (7), 539-546
- https://doi.org/10.1016/j.addr.2010.09.011
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- A Combined Accelerator Mass Spectrometry-Positron Emission Tomography Human Microdose Study with 14C- and 11C-Labelled VerapamilClinical Pharmacokinetics, 2011
- Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitorBioorganic & Medicinal Chemistry, 2010
- A pharmacokinetic evaluation of five H1antagonists after an oral and intravenous microdose to human subjectsBritish Journal of Clinical Pharmacology, 2009
- Radioimmunoimaging with Longer-Lived Positron-Emitting Radionuclides: Potentials and ChallengesBioconjugate Chemistry, 2009
- Imaging multidrug resistance with 4-[18F]fluoropaclitaxelNuclear Medicine and Biology, 2007
- Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugsClinical Pharmacology & Therapeutics, 2006
- Clinical molecular imaging with positron emission tomographyEuropean Journal of Cancer, 2006
- Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug developmentEuropean Journal of Clinical Pharmacology, 2003
- Pharmacokinetic ImagingClinical Pharmacokinetics, 2002
- VerapamilDrugs, 1989